Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Antengene Announces First Patient Dosed of Small Molecule ATR ATG-018 for the Treatment of Patients with Advanced Solid Tumors and Hematologic Malignancies in Australia 2022-08-16 08:30
Gannex Announces First Subject Dosed in the U.S. Drug-Drug Interaction Study of FXR Agonist ASC42 for Treatment of Primary Biliary Cholangitis 2022-08-16 08:10
Everest Medicines Enters into Agreement with Gilead Sciences for Trodelvy in Asia Territories 2022-08-16 07:15
ROKIT Healthcare to Enable Innovation in Treatment of Diabetes Foot and Osteoarthritis Combining AI and 3D Bioprinting on Google Cloud 2022-08-15 07:00
Novavax Nuvaxovid™ COVID-19 Vaccine Approved in South Korea for Use in Adolescents Aged 12 Through 17 2022-08-12 21:39
ROKIT Healthcare to Enable Innovation in Treatment of Diabetes Foot and Osteoarthritis Combining AI and 3D Bioprinting on Google Cloud 2022-08-12 20:00
Seegene reports H1 2022 financial results 2022-08-12 19:00
Top Organizations Lauded with Prestigious Industry Recognition by Frost & Sullivan for Best-in-Class Performance 2022-08-11 20:24
Menarini Group's Elacestrant Granted Priority Review by the U.S. FDA for Patients with ER+/HER2- Advanced or Metastatic Breast Cancer 2022-08-11 20:08
Everest Medicines Announces Regulatory Update and Strategic Partnership for Xerava™ in Taiwan 2022-08-11 08:00
Deep Longevity Selected by Kickstart as One of the Most Promising Start-ups in the World Discussing Proof of Concepts with Big Insurance and Health and Wellbeing Companies 2022-08-10 22:29
NuraLogix researchers announce AI models that can predict Metabolic Risks 2022-08-10 20:15
Recbio announces Phase III Clinical Trial Progress Of Recombinant HPV 9-Valent Vaccine 2022-08-10 16:06
Starpharma signs new DEP® agreement with MSD 2022-08-10 15:29
MedAlliance SELUTION SLR Receives Second FDA IDE Approval 2022-08-10 10:00
Innovent Announces Phase 2 Clinical Study of Picankibart (IBI112) in Chinese Patients with Moderate-to-severe Plaque Psoriasis Met Primary Endpoint 2022-08-10 08:00
ONESIGHT ESSILORLUXOTTICA FOUNDATION ANNOUNCES PUBLICATION OF NEW ARTICLE 2022-08-10 02:00
Frost & Sullivan Institute Recognizes Samsung Biologics with the 2022 Global Enlightened Growth Leadership Award for its Commitment to Sustainable Growth 2022-08-09 21:17
Merck Becomes One of the First CDMOs to Provide Full Viral Vector Offering with Launch of VirusExpress® 293 Adeno-Associated Virus Production Platform 2022-08-09 20:00
Novaliq submits New Drug Application seeking approval for first-of-a-kind Dry Eye Disease Treatment CyclASol® 2022-08-09 19:00
1 178 179 180 181 182 742